Participants 61 98 4
acute myelogenous leukemia in relapse
Participants 130 235 5
Patients with acute myelogenous leukemia in relapse who were ineligible for further anthracycline therapy
Participants 514 525 5
25 patients
Participants 566 568 5
23
